Strategic Portfolio & Alliances Lead

IE02 (FCRS = IE002) Novartis Ireland Ltd; Dublin; Hybrid; EUR 84,000 - 156,000; Full time

Job summary

Novartis Ireland Ltd is seeking a Commercial Portfolio Lead to maximize portfolio value and access across the lifecycle. You will drive go-to-market models, strategic alliances and disciplined lifecycle management, collaborating with country and above-country teams to deliver value in a resource-constrained environment.

The role emphasizes early LOE planning, brand onboarding, and cross-functional alignment with Legal, Value & Access, Supply Chain and Finance to estimate post‑LOE impact.

Qualifications

• Proven track record of P&L and commercial portfolio management responsibility.
• Extensive experience (10+ years) within the pharmaceutical or life sciences industry.

Responsibilities

• Identify and evaluate partnership opportunities to enhance portfolio value.
• Lead negotiations and structure partnerships, licensing or distribution agreements.
• Manage and sustain strategic alliances, ensuring value delivery.
• Pilot international partnership projects with potential to scale at regional or global level.
• Leverage digital channels to maintain brand visibility and regulatory compliance.
• Onboard brands into the commercial portfolio and coordinate with stakeholder teams.

Skills

P&L ownership

Cross-Functional Collaboration

Team Leadership

Data Analytics

Market Research

Digital Marketing

Education

University degree in Science or Business

Advanced degree in Bioscience/Medicine/Business/Management

Job description

Novartis Ireland Ltd is seeking a Commercial Portfolio Lead to maximize portfolio value and access across the lifecycle. You will drive go-to-market models, strategic alliances and disciplined lifecycle management, collaborating with country and above-country teams to deliver value in a resource-constrained environment.

The role emphasizes early LOE planning, brand onboarding, and cross-functional alignment with Legal, Value & Access, Supply Chain and Finance to estimate post‑LOE impact.